Free Trial
LON:MDC

Mediclinic International (MDC) Share Price, News & Analysis

Mediclinic International logo

About Mediclinic International Stock (LON:MDC)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
501
501
52-Week Range
N/A
Volume
925,841 shs
Average Volume
2.68 million shs
Market Capitalization
£3.69 billion
P/E Ratio
2,178.26
Dividend Yield
0.60%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MDC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mediclinic International and its competitors with MarketBeat's FREE daily newsletter.

MDC Stock News Headlines

Critical AI announcement set to ignite AI 2.0
I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.
MDC M.D.C. Holdings, Inc.
Mediclinic International PLC ADR (ANHGY)
Form 8.3 - MDC LN Equity 15-March-23 Dealing Disclosure
See More Headlines

MDC Stock Analysis - Frequently Asked Questions

Shares of MDC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Mediclinic International investors own include Intu Properties (INTU), Capital & Counties Properties PLC (CAPC), British American Tobacco (BATS), Rdi Reit (RDI), Central Asia Metals (CAML), DRDGOLD (DRD) and Spire Healthcare Group (SPI).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Medical Care
Sub-Industry
Construction
Current Symbol
LON:MDC
Previous Symbol
LON:ANH
CIK
N/A
Fax
N/A
Employees
1,640
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX 0.23
Trailing P/E Ratio
2,178.26
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
£169 million
Net Margins
4.99%
Pretax Margin
N/A
Return on Equity
5.50%
Return on Assets
2.30%

Debt

Debt-to-Equity Ratio
78.38
Current Ratio
1.49
Quick Ratio
1.38

Sales & Book Value

Annual Sales
£3.38 billion
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
8.05
Book Value
GBX 481 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
737,240,000
Free Float
N/A
Market Cap
£3.69 billion
Optionable
Not Optionable
Beta
0.42
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (LON:MDC) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners